Shape the future of patient access in Switzerland – combining strategic innovation with hands-on market access leadership across one of the most dynamic healthcare systems in Europe. Your new role This is a unique opportunity where
Oncology Regional Area Lead – Fixed term 12 Months initially, potentially extendable to 18 months Location: Baar, Switzerland Working model: Hybrid, 50% office based and 50% field based Function: Commercial Excellence, Oncology Make an impact where
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)